We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Final Guidance on Glycerin, High-Risk Drug Components Aims to Prevent Poisonings
FDA Final Guidance on Glycerin, High-Risk Drug Components Aims to Prevent Poisonings
The FDA has issued a final guidance to help manufacturers prevent the use of glycerin and other high-risk drug components contaminated with the toxic substances diethylene glycol (DEG) or ethylene glycol (EG), to combat a rise in fatal consumer poisonings.